FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent(r) (alirocumab) Injection for Patients with Hypercholesterolemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent(r) (alirocumab) Injection for Patients with Hypercholesterolemia
BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 13.71 +0.21 (1.56%)
Previous Close $13.50    52 Week High $5.58 
Open $13.70    52 Week Low $3.60 
Day High $13.75    P/E N/A 
Day Low $13.65    EPS $0.00 
Volume 6,053,205       

SANOFI (NASDAQ: SNY) Delayed: 41.78 -0.6 (1.42%)
Previous Close $42.38    52 Week High $44.76 
Open $40.91    52 Week Low $36.81 
Day High $41.82    P/E N/A 
Day Low $40.89    EPS $0.00 
Volume 5,751,327